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Editorial
IntRoductIon
Latent tuberculosis
Patients with latent tuberculosis are asymptomatic even though 
these individuals are, however, infected with Mycobacterium 
tuberculosis, which are alive but are not active.[1] These patients 
have a normal chest X‑Ray and have a negative sputum assay. 
Those patients with latent are not infectious and cannot spread 
a tuberculosis (TB) infections to others.[1]
ActIve tubeRculosIs
The classic symptoms of active TB are a chronic cough with 
blood‑containing sputum, fever, night sweats, and weight 
loss. The historical term “consumption” came about due to 
the weight loss. Infection of other organs can cause a wide 
range of symptoms.[2]
TB is spread through the air when people who have active 
TB in their lungs cough, spit, speak, or sneeze.[2] Diagnosis 
of active TB is based on chest X‑rays, as well as microscopic 
examination and culture of body fluids. Diagnosis of latent TB 
relies on the tuberculin skin test or blood tests.[1,2]
MIcRoRnA expRessIon
MicroRNA’s (microRNA’s) are abundant small, regulatory 
noncoding ribonucleic acid molecules that able to inhibit gene 
expression.[3] The occurrence of these epigenetic markers have 
been found to be present in many cancers, neurodegenerative 
diseases, as well as in a host of infectious diseases.[2] What 
makes these microRNA markers so interesting is that they 
are found in a large variety of biological specimens (i.e., 
peripheral blood, cerebrospinal fluid, and sputum), and their 
presence is seen as early indicators of pathology long before 
the appearance of other markers. This particular fact makes 
them quite potentially useful in the realm of clinical application 
as relates to diagnostics, as well as, a potential indicator of 
the efficacy of a therapeutic regimen. Their potential clinical 
application as relates to the discipline of mycobacteriology, 
especially in cases of suspected TB would be of enormous 
benefit to clinicians.
MicroRNA expression in cases of latent and active 
tuberculosis
The mechanisms associated with latent TB are still rather 
elusive.[4] These microRNA markers have been observed 
to occur in the early onset of disease and would therefore 
be quite useful to clinicians monitoring latent TB patients. 
This is especially the scenario when a patient has reached a 
point of inflection when latent TB is transitioning to active 
MicroRNA markers would thus enable a clinician to make 
an accurate determination that a patient is transitioning from 
latent to active long before the classical markers of active TB 
are positive. The presence of these microRNAs, therefore, 
facilitates the application of an antibiotic therapeutic regimen 
earlier on. The clinical usefulness of microRNA’s for TB and 
other mycobacterial. Pathogens have been investigated in 
several research studies involving peripheral mononuclear 
cells and sputum specimens derived from patients with latent 
and active TB.[4,5] These early research studies did indicate 
that microRNAs were differentially expressed in patients with 
latent and active TB.[4]
MicroRNA presence in sputum in active tuberculosis
Yi et al. found that when sputum samples of patients with 
pulmonary TB were compared with control sputum samples; 
there was a difference in expression of microRNA’s in the 
active TB patient sputum samples.[5] This research study 
observed that there was an over‑expression of miR‑179, 
miR‑147, and underexpression of miR‑19b‑2 in TB group 
compared with controls.[5] This study thus provided the basis 
for a potential utilization of microRNAs in the clinical realm 
for therapeutic‑based applications.[5]
MicroRNA signature in the peripheral blood of patients 
with in pulmonary tuberculosis
The of investigation of Latorre et al. found that there occurred 
a microRNA signature in whole peripheral blood derived from 
patients with pulmonary TB.[6]
conclusIon
Research investigations involving microRNA’s derived 
from mononuclear cells, sputum, and whole peripheral 
blood specimens derived from patients with active TB 
when compared with control patient and latent patient 
groups have shown that these epigenetic markers have a 
potentially useful application for clinicians. The utility of 
these microRNA epigenetic markers is especially interesting 
as relates to diagnostics and applications for early detection 
of TB, as well as, a potential for monitoring the efficacy of 
specific therapeutic regimens based on changes in microRNA 
presence. These microRNA markers could also be of great 
worth to clinicians monitoring patients with latent TB since 
the changes in microRNA presence could be an early indicator 
of when a patient with latent TB converts to a case of active 
TB long before traditional markers for active TB disease turn 
positive!
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